Recent VYGR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 08:43:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/02/2024 08:26:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:09:19 PM
- Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected • GlobeNewswire Inc. • 09/16/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 12:06:12 PM
- Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14 • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/29/2024 08:01:00 PM
- Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences • GlobeNewswire Inc. • 08/29/2024 11:00:00 AM
- Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/06/2024 08:11:30 PM
- Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results • GlobeNewswire Inc. • 08/06/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:00:13 PM
- Voyager Therapeutics Announces Second Quarter 2024 Conference Call and Webcast • GlobeNewswire Inc. • 07/30/2024 11:00:00 AM
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/23/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:11:23 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:10:34 PM
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/09/2024 08:01:00 PM
- Voyager Therapeutics to Present at Multiple Virtual Investor Conferences • GlobeNewswire Inc. • 06/13/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 11:06:00 AM
- Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:22:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:20:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:19:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:17:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:15:13 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM